Cite
HARVARD Citation
Su, Y. et al. (2021). Anxiety symptom remission is associated with genetic variation of PTPRZ1 among patients with major depressive disorder treated with escitalopram. Pharmaocogenetics and genomics. 31 (8), pp. 172-176. [Online].